- NCIt
- C4443
Loading cancer entity…
Loading cancer entity…
Clinical trials
55 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07845617 | Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma | recruiting | — | 10 | AdventHealthOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT07081360 | Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer | recruiting | Phase 3 | 262 | Minia UniversityOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07780838 |
| Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma |
| recruiting |
| Phase 2 |
| 29 |
| Ohio State University Comprehensive Cancer CenterOTHER |
| 1 |
| Sep 10, 2026 |
| clinicaltrials |
| NCT07282912 | Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels(OLIGOMETS) | recruiting | Phase 2 | 54 | Yale UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT05506943 | A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) | active not recruiting | Phase 2 / Phase 3 | 168 | Compass TherapeuticsINDUSTRY | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07283939 | Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays | recruiting | N/A | 420 | Alliance for Clinical Trials in OncologyOTHER | 3 | Sep 2, 2026 | clinicaltrials |
| NCT05497531 | Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers | recruiting | N/A | 15 | University of California, IrvineOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07793253 | Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer | not yet recruiting | Phase 2 | 55 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07744087 | Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas | recruiting | N/A | 232 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT05780684 | Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer | recruiting | N/A | 36 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT02757859 | WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer | active not recruiting | N/A | 845 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07560540 | Nutritional Intervention Implication in Enhanced Recovery After Surgery for Whipple Procedure({ERAS}) | recruiting | N/A | 20 | University of Veterinary and Animal Sciences, Lahore - PakistanOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07446543 | Effect of Negative-Pressure Drainage Versus Pancreatic Duct Stenting for Preventing Pancreatitis After Endoscopic Papillectomy for Duodenal Papillary Tumors | not yet recruiting | N/A | 132 | Cui XiaobingOTHER | 0 | Mar 4, 2026 | clinicaltrials |
| NCT04907643 | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | recruiting | N/A | 360 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT04763642 | The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone | completed | N/A | 320 | State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical HospitalOTHER_GOV | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07328607 | Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy | recruiting | N/A | 90 | Minia UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07262957 | Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)(PANENCA) | recruiting | Phase 4 | 400 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT04400357 | Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors(PORTAL) | completed | N/A | 268 | Ruijin HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT06333314 | Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI(Pan-MSI-ACSE) | recruiting | Phase 2 | 120 | UNICANCEROTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT04526886 | Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy | completed | N/A | 52 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT07199127 | Duodenal Polyposis Classification in FAP(DRACO) | recruiting | — | 300 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT05116072 | Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula(TPIAT-01) | recruiting | Phase 1 / Phase 2 | 36 | University Hospital, LilleOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT03494543 | Endoscopic Papillectomy for Ampullary Adenomas(Papillectomy) | completed | — | 62 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 0 | Jun 11, 2025 | clinicaltrials |
| NCT05251233 | Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy | terminated | Phase 2 | 56 | Washington University School of MedicineOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06648746 | Predictors of Therapeutic Success and Adverse Events in Endoscopic Ampullectomy | not yet recruiting | — | 100 | Universidade do PortoOTHER | 0 | Oct 18, 2024 | clinicaltrials |
| NCT04104230 | Quebec Pancreas Cancer Study(QPCS) | unknown | — | 2,000 | George ZogopoulosOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06258824 | MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers(MIRABILE) | completed | — | 229 | Imperial College LondonOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT01825603 | ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer | completed | Phase 1 | 17 | University of NebraskaOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT04596865 | Recurrence After Whipple's (RAW) Study | completed | — | 1,484 | University Hospital Plymouth NHS TrustOTHER | 8 | Nov 18, 2023 | clinicaltrials |
| NCT06076252 | Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma | enrolling by invitation | N/A | 150 | Affiliated Hospital of Guangdong Medical UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06068023 | The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.(ADAPTA) | recruiting | — | 400 | Fondazione Poliambulanza Istituto OspedalieroOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT06062485 | Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma | not yet recruiting | Phase 2 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Oct 2, 2023 | clinicaltrials |
| NCT02333188 | Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer | completed | Phase 1 | 50 | University of ChicagoOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT02351765 | ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers(ABC-08) | completed | Phase 1 | 21 | The Christie NHS Foundation TrustOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05690412 | Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.(PaNETh) | unknown | — | 400 | Azienda Unità Sanitaria Locale della RomagnaOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT01844245 | Endobiliary RFA for Unresectable Malignant Biliary Strictures | completed | N/A | 174 | Bing HuOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT01208103 | Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 3, 2020 | clinicaltrials |
| NCT03494023 | EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice(ECCO) | completed | — | 539 | Clinical Hospital ColentinaOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04022408 | To Study the Role of Liquid Based Cytology (LBC) for Diagnosis and Characterization of Biliopancreatic Tumor s Compared With Standard Cytology and On-site Evaluation. | unknown | N/A | 60 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT03267966 | Margin Status After Pancreaticoduodenectomy for Cancer | completed | N/A | 168 | Campus Bio-Medico UniversityOTHER | 0 | Feb 6, 2020 | clinicaltrials |
| NCT01926236 | Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers(ABC06) | completed | Phase 3 | 162 | The Christie NHS Foundation TrustOTHER | 1 | Jan 28, 2020 | clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT03150615 | Enteral Nutrition After Pancreaticoduodenectomy | completed | N/A | 120 | Nanjing Medical UniversityOTHER | 1 | Jul 12, 2019 | clinicaltrials |
| NCT01438385 | Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders | unknown | — | 12,000 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT01522573 | T-EUS for Gastrointestinal Disorders: A Multicenter Registry(EUSERCPReg) | unknown | — | 1,000 | Weill Medical College of Cornell UniversityOTHER | 2 | Feb 20, 2017 | clinicaltrials |
| NCT00753675 | Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer(VANGOGH) | completed | Phase 2 | 174 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Oct 10, 2016 | clinicaltrials |
| NCT02165852 | Comparison on the Efficacy of Endoscopic Snare Papillectomy With or Without Submucosal Injection | completed | Phase 3 | 50 | Soon Chun Hyang UniversityOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT02081131 | Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)(PLOT) | completed | N/A | 64 | GEM Hospital & Research CenterOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT00660699 | A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | completed | Phase 2 | 50 | Washington University School of MedicineOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT02238613 | Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer | unknown | N/A | 140 | 307 Hospital of PLAOTHER | 1 | Sep 12, 2014 | clinicaltrials |
Data updated 10 hours agoSource updated Sep 29, 2026source: clinicaltrials